HCW Biologics Inc.
HCWB
$6.02
$0.132.21%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -11.40M | -24.75M | -30.02M | -37.33M | -38.37M |
| Total Depreciation and Amortization | 1.52M | 1.36M | 1.18M | 776.40K | 925.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -651.40K | 1.19M | 1.01M | 6.23M | 6.17M |
| Change in Net Operating Assets | -2.03M | 8.07M | 13.60M | 15.04M | 13.32M |
| Cash from Operations | -12.56M | -14.14M | -14.23M | -15.29M | -17.95M |
| Capital Expenditure | -150.50K | -131.90K | -261.60K | -3.86M | -4.46M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 0.00 | 10.00M |
| Cash from Investing | -150.50K | -131.90K | -261.60K | -3.86M | 5.54M |
| Total Debt Issued | 3.36M | 5.16M | 6.91M | 6.53M | 3.70M |
| Total Debt Repaid | -124.00K | -122.20K | -119.40K | -117.70K | -97.10K |
| Issuance of Common Stock | 12.22M | 6.92M | 9.42M | 2.52M | 2.52M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.46M | -660.30K | -638.00K | -- | -- |
| Cash from Financing | 13.99M | 11.29M | 15.57M | 8.93M | 6.12M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.28M | -2.98M | 1.08M | -10.22M | -6.29M |